The parasite responsible for a form of malaria now spreading from macaques to humans in South Asia could evolve to infect humans more efficiently, a step toward enhanced transmission between humans, according to a new study from Harvard T.H. Chan School of Public Health. The researchers say that defining the means by which the Plasmodium knowlesi parasite invades red blood cells could lead to interventions to prevent the emergence of the zoonosis into the human population.
The researchers identified a sugar variant on the surface of human red blood cells that currently limits the ability of P. knowlesi to invade, and demonstrated that the monkey malaria parasite has the ability to evolve to get around this barrier and pass into the human population in a more virulent form.
The study will appear online April 4, 2016 in Nature Communications.
"With increasing concern about the spread of P. knowlesi into human populations, it is great to be able to gain insight into what the molecular stumbling blocks are for P. knowlesi infection of humans, and how the parasite can potentially overcome them," said first author Selasi Dankwa, who carried out the work while a doctoral student in the Department of Immunology and Infectious Diseases at Harvard Chan School.
The macaque malaria parasite P. knowlesi has emerged as a major source of human infections in Southeast Asia, as the monkey's habitats are encroached upon through logging and farming. While most human infections are mild, increasing numbers of severe infections are being reported, leading to concerns that the parasite is adapting to infect humans more efficiently.
The researchers used a unique stem cell-based genetic approach for interrogating the host red blood cell to explore the parasite's ability to invade and adapt. They did an experiment that introduced the macaque sugar variant onto the human red blood cell surface and demonstrated that the parasite normally dependent on the macaque variant for invasion was unable to use the human version, limiting its virulence. However, worryingly, following prolonged adaptation to growth on human red blood cells, parasites were able to overcome their dependency on the sugar pathway and find another way into the human cell.
The researchers call for continued monitoring of the parasite to ensure that it has not switched to using a sugar-independent pathway to invade red blood cells--a likely prerequisite for human-to-human transmission.
Manoj Duraisingh, John LaPorte Given Professor of Immunology and Infectious Diseases, was the study's senior author. Other Harvard Chan School authors include Caeul Lim, Amy Bei, Rays Jiang, Saurabh Patel, Jonathan Goldberg, Yovany Moreno, and Maya Kono.
The study was supported by a National Institutes of Health grant AI091787 to M.T.D., a Center for Disease Control grant (R36-CK000119-01) and an Epidemiology of Infectious Disease and Biodefense Training Grant (2-T32-AI007535-12) to A.K.B., a National Institute of General Medical Sciences (NIGMS) Biotechnology Training Grant 5-T32-GM08334 to J.R.A. and National Institutes of Health Director's New Innovator Award 1DP2OD007124, NIGMS Center for Integrative Synthetic Biology Grant P50-GM098792, Ferry Award and Massachusetts Institute of Technology Startup funds to J.C.N. S.D.P. was supported by a National Institutes of Health Pediatric Scientist Development Program grant 5-K12-HD000850. Y.M. is a recipient of the Louis-Berlinguet Program Postdoctoral Research Scholarship in Genomics-Fonds de recherche du Quebec, Nature et technologies.
Reference: "Ancient human sialic acid variant restricts an emerging zoonotic malaria parasite," Selasi Dankwa, Caeul Lim, Amy K. Bei, Rays H.Y. Jiang, James R. Abshire, Saurabh D. Patel, Jonathan M. Goldberg, Yovany Moreno, Maya Kono, Jacquin C. Niles, and Manoj T. Duraisingh, Nature Communications, online April 4, 2016, doi: 10.1038/ncomms11187
Source: Harvard T.H. Chan School of Public Health
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.